Navigation Links
Lower autism risk with folic acid supplements in pregnancy
Date:2/12/2013

Women who took folic acid supplements in early pregnancy almost halved the risk of having a child with autism. Beginning to take folic acid supplements later in pregnancy did not reduce the risk. This is shown in new findings from the ABC Study and Norwegian Mother and Child Cohort Study published in the Journal of The American Medical Association (JAMA).

Women who took folic acid supplements from four weeks before conception to eight weeks into pregnancy had a 40 per cent lower risk of giving birth to children with childhood autism (classic autism). Use of folic acid supplements midway through pregnancy (week 22) had no effect.

The findings only apply to a lower risk of childhood autism, the most severe form of autism. The results show no reduction in the risk of atypical or unspecific autism. The study also investigated the prevalence of Asperger syndrome, but the number of examined children was too low to give a reliable result.

Food and other supplements did not reduce risk

The researchers found no connection between childhood autism and intake of other supplements during pregnancy. They also found no correlation with maternal intake of folate through food.

"It appears that the reduced risk of childhood autism only reflects folic acid supplements, not food or other supplements, and that the crucial time interval is from four weeks before conception to eight weeks into pregnancy," says Dr Pl Surn, primary author of the paper and researcher at the Norwegian Institute of Public Health.

Clear results that pave the way for further research

The results show an association between the use of folic acid supplements in the mother during pregnancy and a reduced risk of childhood autism.

"The study does not prove that folic acid supplements can prevent childhood autism. However, the findings are so apparent that they constitute a good argument to further examine
'/>"/>

Contact: Julie Johansen
julie.johansen@fhi.no
Norwegian Institute of Public Health
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Can computers save health care? IU research shows lower costs, better outcomes
2. Anxiety about relationships may lower immunity, increase vulnerability to illness
3. Lower Drinking Age May Raise Chances of Bingeing Later
4. Winter Storm Hazard: Snowblower Injuries
5. Lower drinking ages lead to more binge drinking
6. Too Much TV Tied to Lower Sperm Count in Young Men
7. Sunshine Linked to Lower Rheumatoid Arthritis Risk: Study
8. Patient Involvement Lowers Health Costs, Study Says
9. Plastic Surgery Practice Gets Boost from Lower Eyelid Surgery Webinar
10. Higher Fruit, Veggie Intake Tied to Lower Risk of a Tough-to-Treat Breast Cancer
11. Study Links Epilepsy Drug in Pregnancy to Lower IQ
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... People in Minnesota have a great option ... offering its 28 Day Fat Loss Formula. The best ... of their own home. The product sells for $135 dollars ... be accessed here: http://altmanfitness.com/28-day-fat-loss-formula/ , “Bikini season is ... now, but after using the 28 Day Fat Loss Formula ...
(Date:5/19/2013)... New York (PRWEB) May 19, 2013 ... in a federal litigation now underway in U.S. District ... Case Management Order dated May 3rd, the Court has ... Nominee Pool to eight cases rather than four. The ... scheduled for Thursday, May 23rd. (In re: Actos Product ...
(Date:5/19/2013)... City, Utah (PRWEB) May 19, 2013 ... information on small business health insurance . ... to traditional employer sponsored health benefits, is the ... and health reimbursement arrangements . , ... start-ups, and the self-employed intrinsically know the value ...
(Date:5/19/2013)... According to a new market research report ... 2018): By Applications (Healthcare (Endoscopy, Radiology, Ophthalmology), Surveillance, ... IS, Infrared, X-Ray) And Geography" published by MarketsandMarkets, ... billion in 2012 and is expected to reach ... of 3.84% from 2013 to 2018. In terms ...
(Date:5/19/2013)... 19, 2013 These molecular diagnostics ... UK, Spain, Japan, Italy, Germany and France:, ... diagnostics laboratory practice, as well as key economic, ... market impact during the next five years. , ... biochip technologies, test formats, detection methodologies, trends in ...
Breaking Medicine News(10 mins):Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 2Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 3Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 2Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 4
... 31, 2008) Real-world use of a novel drug-eluting ... good clinical outcomes, according to one-year data from a ... focused on the sirolimus-eluting Excel stent, are being reported ... SCAI Annual Scientific Sessions in Partnership with ACC i2 ...
... 31, 2008) A large community-based registry of patients ... how long patients with complex coronary artery disease typically ... drug that prevents unwanted blood clots; why they stop ... decision. , The new data from the MATRIX ...
... Percutaneous coronary intervention (PCI) may be a reasonable ... the left main coronary artery, according to a study ... when stents and bypass surgery were used to restore ... were treated with stenting were more likely to need ...
... refined salt prompt consumers, food industry to consider ... benefits of natural sea ... chemicals over a dinner plate - yet that,s exactly what millions,of ... food,with refined table salt, says Mark Zoske, co-founder of SaltWorks, Inc.,( ...
... Teleconference Tuesday, April 1, 2008 at 9:30 AM EDT, ... Bulletin Board: MLSS), the recognized leader in,advanced injection technologies, ... fiscal year, ended December 31, 2007., Key ... System was formally unveiled to market at ...
... Pharmaceutical Holdings, Inc. (Amex: KUN ) ("China ... research, development, manufacture,and marketing of pharmaceutical, nutritional supplement ... ("PRC"), today announced it will,conduct a conference call ... 2008, to,discuss the Company,s financial results for the ...
Cached Medicine News:Health News:Registry unveils 'real-world' data on novel excel stent 2Health News:Matrix registry probes adherence to clopidogrel at 1 year 2Health News:Matrix registry probes adherence to clopidogrel at 1 year 3Health News:Study finds support for PCI in unprotected left main disease 2Health News:Study finds support for PCI in unprotected left main disease 3Health News:SaltWorks, Inc. Advises Table Salt Alternatives 2Health News:Milestone Scientific Announces 2007 Year-End Results 2Health News:Milestone Scientific Announces 2007 Year-End Results 3Health News:Milestone Scientific Announces 2007 Year-End Results 4Health News:Milestone Scientific Announces 2007 Year-End Results 5Health News:Milestone Scientific Announces 2007 Year-End Results 6Health News:Milestone Scientific Announces 2007 Year-End Results 7Health News:China Shenghuo Pharmaceutical Holdings, Inc. Schedules Conference Call to Discuss FY 2007 Results 2Health News:China Shenghuo Pharmaceutical Holdings, Inc. Schedules Conference Call to Discuss FY 2007 Results 3
(Date:5/16/2013)... NORTH CHICAGO, Ill. and MECHELEN, ... NV (Euronext: GLPG) and AbbVie (NYSE: ABBV ... development collaboration to include Crohn,s disease.  Galapagos will fund ... which is designed to facilitate rapid progression into Phase ... Q2 2015, AbbVie will pay Galapagos $50 million.  The ...
(Date:5/16/2013)... 2013  Today, the National Patient Advocate Foundation acknowledges ... of Representatives recently approved a bill that would prohibit ... higher out-of-pocket fees for newer, more expensive oral anti-cancer ... more severe side-effects. However, the bill was amended to ... continue to be a barrier to patients with cancer ...
(Date:5/16/2013)... May 16, 2013  Amgen (NASDAQ: AMGN ) ... Tuesday, May 21, 2013, at the Sheraton New York Times ... at 10:00 a.m. Eastern Daylight Time. Joseph P. ... and Development at Amgen, will present at the conference. Live ... Calendar on Amgen,s website, www.amgen.com , under Investors. A ...
Breaking Medicine Technology:AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
... LONDON , March 17, 2010 Hikma Pharmaceuticals,today announced 2009 preliminary results with operating profits up 36% on the,back of a strong performance from its Middle East ... , ... ... ...
... 16 American pharmaceutical manufacturer Alpharma Inc. has agreed ... Act allegations in connection with the marketing of the morphine-based ... allegations that, between January 1, 2000 and ... induce them to promote or prescribe Kadian, and made misrepresentations ...
Cached Medicine Technology:Hikma 2009 Results Interviews With CEO and CFO 2Alpharma to Pay $42.5 Million to Resolve False Claims Act Allegations in Connection With Promotion of Drug Kadian 2Alpharma to Pay $42.5 Million to Resolve False Claims Act Allegations in Connection With Promotion of Drug Kadian 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: